Position in ALKS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$307,384
+$54,165 QoQ
Shares Held
8,693
-3.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HOHIMER WEALTH MANAGEMENT, LLC holds $5,927,916 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
221,100 | $4,590,036 | |
| 2 | ALKS |
Alkermes plc.
This page
|
8,693 | $307,384 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
3,481 | $267,688 | |
| 4 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
13,066 | $255,962 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
7,713 | $255,068 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
4,248 | $251,778 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $307,384 | 8,693 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $253,219 | 9,050 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $322,650 | 10,755 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $266,616 | 9,319 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $408,193 | 12,362 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $342,589 | 11,912 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $314,691 | 11,243 | Shares | Sole | 2024-11-19 | |
| No filing history on record for this holder in this stock. | ||||||